Financials
Financial year 2025
L.V.G. PHARMA from Puurs-Sint-Amands, company number BE0861341984, closed financial year 2025 with a result of € 99,130 after tax. For that financial year L.V.G. PHARMA recorded a gross margin of € 122,290 and equity of € 799,333. Compared with financial year 2024, the result moved from € 90,777 to € 99,130. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 27, 2026.
€ 799,333
▲ 14% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 99,130
▲ 9% vs 2024
Profit after tax over the fiscal year.
€ 57,188
▼ 50% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 650 paid out
1 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 1,304
▼ 17% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 210,000
Loans from banks and other lenders, long and short.
€ 23,425
▼ 16% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 124,802 | € 121,670 | € 122,887 | € 122,290 | |
| Profit after taxes | € 92,185 | € 90,823 | € 90,777 | € 99,130 | ▲ 9% |
| Equity | € 730,603 | € 715,725 | € 700,853 | € 799,333 | ▲ 14% |
| Total debts | € 316,415 | € 361,908 | € 364,164 | € 257,688 | ▼ 29% |
| Cash | € 196,287 | € 127,591 | € 114,541 | € 57,188 | ▼ 50% |
| Retained profit | € 718,203 | € 703,325 | € 688,453 | € 786,933 | ▲ 14% |
| Dividend | € 57,874 | € 105,700 | € 105,650 | € 650 | ▼ 99% |
| Bank debt | € 210,000 | € 210,000 | € 210,000 | € 210,000 | |
| Balance sheet total | € 1,047,018 | € 1,077,634 | € 1,065,017 | € 1,057,021 | ▼ 1% |
Key figures of L.V.G. PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to L.V.G. PHARMA?
What happened at L.V.G. PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 99,130 (▲ 9% vs 2024). Source: NBB ↗
- New establishment in Puurs-Sint-Amands. KBO
- Start of the company according to the CBE. KBO
In short
From € 92,185 profit in 2022 to € 99,130 profit in 2025.
Paid € 151,642 in corporate taxes since 2022.
Best year ever: 2025, with € 99,130 profit.
Paid out € 269,874 in dividends to the owners in total.
Management
Behind L.V.G. PHARMA is Godelieve Van Achter. It owns 100% of apotheek Vanachter itself.
Directors
According to the 2025 annual accounts
Godelieve Van Achter
Director
Establishments
Establishment units
Physical locations of this company
Kleine Amer 49
2870 Puurs-Sint-Amands
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0861.341.984
- VAT number
- BE 0861.341.984
- Registered office
- Kleine Amer 49, 2870 Puurs-Sint-Amands
- Names & denominations
- L.V.G. PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 October 2003
- Peppol
- Active · Active since 29 Jul 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers